Source: Singular Health Group
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Medical technology company Singular Health Ltd (ASX:SHG) has launched an updated version of its DICOM viewer – which allows patients to interact with standard 2D medical images, including MRI (magnetic resonance imaging) and CT (computerized tomography) scans, in 3D – with this product set to better facilitate management of and engagement with medical records.

The new 3Dicom online viewer includes features such as interactive tutorials, annotations from 3Dicom MD, and integration with ChatGPT 3.5 AI which will enable semi-automated patient education prompts.

Increased accessibility is a key part of the technology offering, as it addresses the problem of patients needing to download desktop applications for Windows or MacOS in order to see and interact with their medical records.

Managing director Denning Chong said the launch reflected Singular Health’s development of user-friendly engagement with their medical data.

“The recent evolution of the 3Dicom software is the technical catalyst for future growth as we open up additional commercial avenues through licensing, easier integration with outputs from AI models, and ‘one-click’ solutions for storage and sharing,” he said.

“This new online viewer retains the spirit of the 3Dicom software, with on-device anonymisation prior to upload, on-device rendering rather than server-based rendering, and numerous other technical innovations that improve accessibility and performance whilst also minimising the usual running costs of cloud-based solutions.”

Singular brought on Cloud-based development in March this year, developing this quickly in-line with the demands of existing customers in the United States.

Singular has been trading at 9.2 cents.

SHG by the numbers
More From The Market Online
The Market Online Video

ASX Market Close: Index hits new closing record as switch back to miners continues | September 27, 2024

The ASX200 closed up 0.1% at 8,212 points. The flow away from banks continues to drive…
The Market Online Video

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical…
Cotton ready for harvest, near Warren, in New South Wales, Australia

ACCC seeks Olam divestments before it can buy Namoi Cotton

Australia's market regulator the ACCC has expressed further concerns about the potential takeover of Namoi Cotton…